Screener
AngioDynamics ANGO Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively | 387 | 385 |
| Additional paid-in capital | 636,083 | 621,186 |
| Accumulated deficit | (465,939) | (429,197) |
| Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively | (7,381) | (7,381) |
| Accumulated other comprehensive loss | 7,675 | (2,023) |
| Total Stockholders' Equity | 170,825 | 182,970 |
| Total Liabilities and Stockholders' Equity | $267,163 | $280,144 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's treasury stock, shares (in shares)?
- AngioDynamics (ANGO) reported treasury stock, shares (in shares) of $613.85K in Q1 2026.
Ask your AI about AngioDynamics's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude